Skip to main content
MedWatcherBeta

Loading research and source information…

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) for Multiple sclerosis: evidence and status · MedWatcher